The bone marrow stroma capacity to confer resistance to leukemia cells from Ara-C treatment as a prognostic factor for overall survival in AML.

Patricia Macanas-Pirard,Sergio Vargas-Salas,Richard Broekhuizen,Romina Coronado,Carolina Bizama,Sabrina Muñiz-Muñoz,Vivianne Torres,Viviana P. Montecinos,Daniel Ernst,Francisco Melo,Juan Carlos Roa,Bruno Nervi

The bone marrow stroma capacity to confer resistance to leukemia cells from Ara-C treatment as a prognostic factor for overall survival in AML.

2019

Patricia Macanas-Pirard
Sergio Vargas-Salas
Richard Broekhuizen
Romina Coronado
Carolina Bizama
Sabrina Muñiz-Muñoz
Vivianne Torres
Viviana P. Montecinos
Daniel Ernst
Francisco Melo
Juan Carlos Roa
Bruno Nervi

e18500Background: The interaction of acute myeloid leukemia (AML) with the bone marrow stroma (BMS) determines a protective microenvironment that favors leukemia development and resistance to chemo...

Keywords:

Pathology
Leukemia
Cancer research
Myeloid leukemia
Bone marrow stroma
Medicine
prognostic factor
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations